Immediate Impact
11 standout
Citing Papers
Efficacy, Immunogenicity, and Safety of the Bivalent Respiratory Syncytial Virus (RSV) Prefusion F Vaccine in Older Adults Over 2 RSV Seasons
2025 Standout
A truncated pre-F protein mRNA vaccine elicits an enhanced immune response and protection against respiratory syncytial virus
2025 Standout
Works of Melvin Ochieng being referenced
The Burden of Influenza and RSV among Inpatients and Outpatients in Rural Western Kenya, 2009–2012
2014
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Melvin Ochieng | 30 | 73 | 9 | 17 | 6 | 88 | |
| Isaac Armistead | 30 | 71 | 5 | 39 | 6 | 96 | |
| Chelsea McMullen | 38 | 65 | 3 | 12 | 5 | 104 | |
| Abdurasiet Mowlana | 51 | 63 | 7 | 58 | 8 | 166 | |
| Lidia Albano | 25 | 82 | 5 | 44 | 5 | 127 | |
| Emily K. Johnson | 24 | 87 | 8 | 36 | 4 | 99 | |
| Aroa Villoslada | 56 | 170 | 10 | 28 | 11 | 202 | |
| Andros Theo | 28 | 75 | 8 | 12 | 4 | 86 | |
| D. Postil | 34 | 77 | 6 | 12 | 8 | 103 | |
| Christopher J. Babbitt | 51 | 157 | 4 | 32 | 4 | 191 | |
| Victoria Morris‐Glasgow | 33 | 38 | 3 | 5 | 7 | 59 |
All Works
Login with ORCID to disown or claim papers
Loading papers...